GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dermapharm Holding SE (CHIX:DMPd) » Definitions » EBITDA Margin %

Dermapharm Holding SE (CHIX:DMPD) EBITDA Margin % : 27.29% (As of Mar. 2025)


View and export this data going back to 2018. Start your Free Trial

What is Dermapharm Holding SE EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Dermapharm Holding SE's EBITDA for the three months ended in Mar. 2025 was €83 Mil. Dermapharm Holding SE's Revenue for the three months ended in Mar. 2025 was €302 Mil. Therefore, Dermapharm Holding SE's EBITDA margin for the quarter that ended in Mar. 2025 was 27.29%.


Dermapharm Holding SE EBITDA Margin % Historical Data

The historical data trend for Dermapharm Holding SE's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dermapharm Holding SE EBITDA Margin % Chart

Dermapharm Holding SE Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.15 37.90 32.18 23.39 27.18

Dermapharm Holding SE Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33.18 23.62 27.42 24.85 27.29

Competitive Comparison of Dermapharm Holding SE's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Dermapharm Holding SE's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dermapharm Holding SE's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dermapharm Holding SE's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Dermapharm Holding SE's EBITDA Margin % falls into.


;
;

Dermapharm Holding SE EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Dermapharm Holding SE's EBITDA Margin % for the fiscal year that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=320.908/1180.766
=27.18 %

Dermapharm Holding SE's EBITDA Margin % for the quarter that ended in Mar. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2025 )/Revenue (Q: Mar. 2025 )
=82.53/302.396
=27.29 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dermapharm Holding SE  (CHIX:DMPd) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Dermapharm Holding SE EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Dermapharm Holding SE's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Dermapharm Holding SE Business Description

Traded in Other Exchanges
Address
Lil-Dagover-Ring 7, Grunwald, BY, DEU, 82031
Dermapharm Holding SE manufactures patent-free branded pharmaceuticals for selected therapy fields, over-the-counter drugs, and natural remedies. The portfolio of the company includes cosmetics, nutritional supplements, and diet and medical devices. Business operating segments include Branded pharmaceuticals, which drive key revenue, Other healthcare products, and Parallel import business. The Branded pharmaceuticals segment covers numerous product areas through a wide variety of items sold under reputable brand names.

Dermapharm Holding SE Headlines

No Headlines